Table 1. . Percent inhibition of cancer cell line proliferation in the presence of compounds (1 µM).
Compound | HSN210 | HSN204 | HSM1669 | HSM1812 | HSN137 | HSM1673 | HSM1683 | HSN105 | HSM1610 | HSM1674 | HSN177 | HSM1702 | HSN184 | HSM1750 | HSN145 | HSN139 | HSN135 | HSM1773 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Code | A3 | A4 | A5 | A6 | A7 | A9 | A10 | A11 | A12 | A13 | A14 | A15 | A16 | A17 | A20 | A22 | A23 | A24 |
MV4–11 | 100 | 77 | 83 | 92 | 99 | 98 | 95 | 88 | 90 | 93 | 91 | 99 | 97 | 93 | 99 | 95 | 100 | 93 |
HCT116 | 6 | 21 | 46 | 17 | 60 | 28 | 10 | 40 | 39 | 14 | 15 | 33 | 38 | 20 | 35 | 32 | 21 | 24 |
HeLa | 16 | 22 | 20 | 97 | 20 | 38 | 49 | 1 | 20 | 8 | 1 | 17 | 51 | 11 | 11 | 35 | 0 | 24 |
MCF-7 | 1 | 20 | 98 | 100 | 74 | 56 | 57 | 12 | 29 | 36 | 46 | 100 | 92 | 17 | 6 | 60 | 35 | 43 |